日本6月起將免除八成人士入境檢測及觀察措施
《日經新聞》報道,日本政府公佈放寬入境口岸防疫管理措施,由6月1日起,將免除八成入境人士在入境時檢測及觀察措施。
日本政府表示,根據感染情況和檢測陽性率等風險,將各國和地區劃分爲「藍、黃、紅」等3類,低風險的「藍」一類的入境者無論是否已接種疫苗,均免除入境時的檢測和觀察。3個分類的具體對象將稍後公佈。
另外,自6月1日起,日本入境人數上限從每天1萬人提高至2萬人;同時爲恢復接待遊客,亦接納由美國、澳洲、泰國、新加坡等小型團體遊客的驗證措施。(ca/a)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.